The DOPPS Practice Monitor for US Dialysis Care: PTH Levels and Management of Mineral and Bone Disorder in US Hemodialysis Patients

American Journal of Kidney Diseases

Volumn 66, Issue 3, 2015, Pages 536-539

  Tentori, Francesca ^a,b   Zepel, Lindsay ^a   Fuller, Douglas S ^a   Wang, Mia ^a   Bieber, Brian A ^a   Robinson, Bruce M ^a,c   Pisoni, Ronald L ^a  

^a ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CINACALCET; PARATHYROID HORMONE; VITAMIN D;

BONE DISEASE; HEMODIALYSIS PATIENT; MINERAL AND BONE DISORDER; MORTALITY; PARATHYROID HORMONE BLOOD LEVEL; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; PROSPECTIVE PAYMENT; RENAL REPLACEMENT THERAPY; REVIEW; SECONDARY HYPERPARATHYROIDISM; BLOOD; BONE DISEASES, METABOLIC; HUMAN; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; UNITED STATES;

BONE DISEASES, METABOLIC; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; PARATHYROID HORMONE; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS; UNITED STATES;

EID: 84939537869     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.07.011     Document Type: Article

References (21)

1. W.G. Goodman, J. Goldin, B.D. Kuizon, and et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis N Engl J Med 342 2000 1478 1483
2. A.M. de Francisco, H.A. Ellis, J.P. Owen, and et al. Parathyroidectomy in chronic renal failure Q J Med 55 1985 289 315
3. A. Levin, G.L. Bakris, M. Molitch, and et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease Kidney Int 71 2007 31 38
4. G.M. Chertow, M. Plone, M.A. Dillon, S.K. Burke, and E. Slatopolsky Hyperparathyroidism and dialysis vintage Clin Nephrol 54 2000 295 300
5. F. Malberti, D. Marcelli, F. Conte, A. Limido, D. Spotti, and F. Locatelli Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study J Am Soc Nephrol 12 2001 1242 1248
6. G.A. Block, P.S. Klassen, J.M. Lazarus, N. Ofsthun, E.G. Lowrie, and G.M. Chertow Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 2004 2208 2218
7. Y. Slinin, R.N. Foley, and A.J. Collins Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study J Am Soc Nephrol 16 2005 1788 1793
8. E.W. Young, J.M. Albert, S. Satayathum, and et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study Kidney Int 67 2005 1179 1187
9. K. Kalantar-Zadeh, N. Kuwae, D.L. Regidor, and et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients Kidney Int 70 2006 771 780
10. N. Kimata, J.M. Albert, T. Akiba, and et al. Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study Hemodial Int 11 2007 340 348
11. F. Tentori, M.J. Blayney, J.M. Albert, and et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 52 2008 519 530
12. E. Lacson Jr., W. Wang, R.M. Hakim, M. Teng, and J.M. Lazarus Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access Am J Kidney Dis 53 2009 79 90
13. J. Floege, J. Kim, E. Ireland, et al. ARO Investigators Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population Nephrol Dial Transplant 26 2011 1948 1955
14. F. Tentori, M. Wang, B.A. Bieber, and et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study Clin J Am Soc Nephrol 10 1 2015 98 109
15. S.C. Palmer, A. Hayen, P. Macaskill, and et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis JAMA 305 2011 1119 1127
16. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Kidney Int Suppl 76 suppl S113 2009 S1 S130
17. K. Uhlig, J.S. Berns, B. Kestenbaum, and et al. KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD) Am J Kidney Dis 55 2010 773 799
18. National Kidney Foundation K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis 42 suppl 3 2003 S1 S202
19. F. Tentori, D. Fuller, B. Bieber, and et al. The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral and Bone Disorder Among US Hemodialysis Patients Am J Kidney Dis 63 2014 851 854
20. E.W. Young, D.A. Goodkin, D.L. Mapes, and et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study Kidney Int 57 suppl 74 2000 S74 S81
21. R.L. Pisoni, B.W. Gillespie, D.M. Dickinson, K. Chen, M. Kutner, and R.A. Wolfe The Dialysis Outcomes and Practice Patterns Study: design, data elements, and methodology Am J Kidney Dis 44 suppl 2 2004 S7 S15